Vaccinations in prisons: A shot in the arm for community health

Human Vaccines and Immunotherapeutics

Volumn 11, Issue 11, 2015, Pages 2615-2626

  Sequera, Víctor Guillermo ^a   Valencia, Salomé ^a   García Basteiro, Alberto L ^b,c   Marco, Andrés ^d   Bayas, José M ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^c Manhiça Health Research Center   (Mozambique)

^d Health Services of Barcelona Men's Penitentiary Centre   (Spain)

Author keywords

Communicable diseases; Disease prevention; Health promotion; Prisons; Vaccination

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B CORE ANTIGEN; HEPATITIS VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; MEASLES VACCINE; MENINGOCOCCUS VACCINE; MUMPS VACCINE; PNEUMOCOCCUS VACCINE; RUBELLA VACCINE; WART VIRUS VACCINE;

ARTICLE; CHICKENPOX; COMMUNICABLE DISEASE; COMMUNITY CARE; DIPHTHERIA; DISEASE CONTROL; EPIDEMIC MENINGITIS; HEALTH PROMOTION; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LGBT PEOPLE; MEASLES; MEN WHO HAVE SEX WITH MEN; MENINGOCOCCOSIS; MUMPS; PAPILLOMAVIRUS INFECTION; PERTUSSIS; PNEUMOCOCCAL INFECTION; PRISON; RUBELLA; SEASONAL INFLUENZA; SEROPREVALENCE; TETANUS; TUBERCULOSIS; VACCINATION; WORLD HEALTH ORGANIZATION; DISEASE TRANSMISSION; PREVENTION AND CONTROL; UTILIZATION;

DISEASE TRANSMISSION, INFECTIOUS; HUMANS; PRISONS; VACCINATION;

EID: 84983377006     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1051269     Document Type: Article

References (154)

1. Engginst S, Møller L, Galea G, Udensen C. Prisons and Health. Copenhagen: WHO, Regional Office for Europe; 2014
2. Bick JA. Infection control in jails and prisons. Clin Infect Dis 2007;45(8):1047-55; PMID:17879924; http://dx.doi.org/10.1086/521910
3. Plotkin SL, Plotkin SA. A short history of vaccination. Vaccines. In Plotkin S, Orenstein W, Offit PA. 5th ed. Philadelphia, PA: WB Saunders; 2008
4. Sequera VG, Garcia-Basteiro A, Bayas J. The role of vaccination in prisoners’ health. Expert Rev Vaccines 2013; 12(5):469-71; PMID:23659294; http://dx.doi.org/10.1586/erv.13.28
5. Sequera VG, Bayas JM. Vaccination in the prison population: a review. Rev Esp Sanid Penit 2012; (14): 99-105; PMID:23165633; http://dx.doi.org/10.4321/S1575-06202012000300005
6. Moller L, Stöver H, Jürgens R, Gatherer A, Nikogosian H. Health in Prisons. A WHO guide to the essential in prison health. Copenhagen: WHO, Regional Office for Europe; 2007
7. Hatton DC, Kleffel D, Fisher AA. Prisoners’ perspectives of health problems and healthcare in a US women’s jail. Women Health 2006; 44 (1):119-36; PMID:17182530; http://dx.doi.org/10.1300/J013v44n01_07
8. McGuire J, Rosenheck RA, Kasprow WJ. Health status, service use, and costs among veterans receiving outreach services in jail or community settings. Psychiatr Serv 2003; 54(2):201-7; PMID:12556601; http://dx.doi.org/10.1176/appi. ps.54.2.201
9. National Institute of Statistics. Prison population by nationality, sex and period, Spain 2014. http://www.ine.es/jaxi/tabla.do. Accesed February 15, 2015
10. Hockings B, Young M, Falconer A, O’Rourke PK. Queensland women prisoners’ health survey. Department of Corrective Service: Brisbane; 2002. https://nationalvetcontent.edu.au/alfresco/d/d/workspace/SpacesStore/c6f6a435-62d2-4c90-b052-42904ac2f 5e3/701/shared/content/resources/health_women2.pdf. Accessed January 11, 2015
11. Bickell N, Vermund S. Human papillomavirus, gonorrhea, syphilis, and cervical dysplasia in jailed women. Am J Public Heal 1991; 81(10):1318-20; PMID:1928533; http://dx.doi.org/10.2105/AJPH.81.10.1318
12. Williams B, Goodwin J. Addressing the aging crisis in US criminal justice health care. J Am Geriatr Soc 2012; 60(6):1150-6; PMID:22642489; http://dx.doi. org/10.1111/j.1532-5415.2012.03962.x
13. Besdine R, Boult C, Brangman S, Coleman EA, Fried LP, Gerety M, Johnson JC, Katz PR, Potter JF, Reuben DB, et al. Caring for older Americans: the future of geriatric medicine. J Am Geriatr Soc 2005; 53(6 Suppl):S245-56; PMID:15963180
14. Williams BA, McGuire J, Lindsay RG, Baillargeon J, Cenzer IS, Lee SJ, Kushel M. Coming home: health status and homelessness risk of older pre-release prisoners. J Gen Intern Med 2010; 25(10):1038-44; PMID:20532651; http://dx.doi.org/10.1007/s11606- 010-1416-8
15. Baillargeon J, Black SA, Leach CT, Jenson H, Pulvino J, Bradshaw P, Murray O. The infectious disease profile of Texas prison inmates. Prev Med 2004; 38 (5):607-12; PMID:15066363; http://dx.doi.org/10.1016/j.ypmed.2003.11.020
16. European Monitoring Centre for Drugs and Drug Addiction. Prisons and Drugs in Europe: the problem and responses. Luxembourg: Publication Office of the European Union; 2012. http://www.emcdda.europa. eu/publications/selected-issues/prison.Accessed January 11, 2015
17. Ritter C, Stover H, Levy M, Etter JF, Elger B. Smoking in prisons: the need for effective and acceptable interventions. J Public Health Policy 2011; 32(1):32-45; PMID:21160535; http://dx.doi.org/10.1057/jphp.2010.47
18. Fazel S, Bains P, Doll H. Substance abuse and dependence in prisoners: a systematic review. Addiction 2006; 101(2):181-91; PMID:16445547; http://dx.doi.org/10.1111/j.1360-0443.2006.01316.x
19. Binswanger IA, Krueger PM, Steiner JF. Prevalence of chronic medical conditions among jail and prison inmates in the USA compared with the general population. J Epidemiol Community Health 2009 Nov; 63(11):912-9; PMID:19648129; http://dx.doi.org/10.1136/jech.2009.090662
20. Fazel S, Baillargeon J. The health of prisoners. Lancet 2011; 377(9769):956-65; PMID:21093904; http://dx.doi.org/10.1016/S0140-6736(10)61053-7
21. Thorburn K. Health care in correctional facilities. West J Med 1995; 163(6):560-4; PMID:8553640
22. Mathew P, Elting L, Cooksley C, Owen S, Lin J. Cancer in an incarcerated population. Cancer 2005; 104 (10):2197-204; PMID:16206295; http://dx.doi.org/10.1002/cncr.21468
23. Garcia-Guerrero J, Vera-Remartinez EJ, Planelles Ramos MV. [Causes and trends of mortality in a Spanish prison (1994-2009)]. Rev Esp Salud Publica 2011 Jun; 85(3):245-55; PMID:21892549; http://dx.doi.org/10.1590/S1135-57272011000300003
24. Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, Scano F. Tuberculosis incidence in prisons: a systematic review. PLoS Med 2010; 7(12): e1000381; PMID:21203587; http://dx.doi.org/10.1371/journal.pmed.1000381
25. World Hearlh Organization. Global Tuberculosis Report 2013. http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656éng.pdf. Accessde January 11, 2015
26. Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health 2002; 92(11):1789-94; PMID:12406810; http://dx.doi.org/10.2105/AJPH.92.11.1789
27. Spaulding A, Stephenson B, Macalino G, Ruby W, Clarke JG, Flanigan TP. Human immunodeficiency virus in correctional facilities: a review. Clin Infect Dis 2002; 35(3):305-12; PMID:12115097; http://dx.doi.org/10.1086/341418
28. Kirwan P, Evans B, Brant L. Hepatitis C and B testing in English prisons is low but increasing. J Public Health 2011; 33(2):197-204; PMID:21345883; http://dx.doi.org/10.1093/pubmed/fdr011
29. Adjei AA, Armah HB, Gbagbo F, Ampofo WK, Quaye IKE, Hesse IF, Mensah G. Correlates of hepatitis C virus infection among incarcerated Ghanaians: a national multicentre study. J Med Microbiol 2007; 56(Pt 3):391-7; PMID:17314372; http://dx.doi.org/10.1099/jmm.0.46859-0
30. Mohamed HI, Saad ZM, Abd-Elreheem EM, Abd- ElGhany WM, Mohamed MS, Abd Elnaeem EA, Seedhom AE. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases. J Infect Public Health 2013; 6(3):186-95; PMID:23668463; http://dx.doi.org/10.1016/j.jiph.2012.12.003
31. Saiz de la Hoya P, Marco A, García-Guerrero J, Rivera A. Hepatitis C and B prevalence in Spanish prisons. Eur J Clin Microbiol Infect Dis 2011; 30 (7):857-62; PMID:21274586; http://dx.doi.org/10.1007/s10096-011-1166-5
32. Gough E, Kempf MC, Graham L, Manzanero M, Hook EW, Bartolucci A, Chamot E. HIV and hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis. BMC Public Health 2010; 10:777; PMID:21176146; http://dx.doi.org/10.1186/1471-2458-10-777
33. Pomplillo MA, Pontes E, Castro A, Andrade SM, Stief AC, Martins RM, Mousquer GJ, Murat PG, Francisco RB, Pompilio S, et al. Prevalence and epidemiology of chronic hepatitis C among prisoners of Mato Grosso do Sul State, Brazil. J Venom Anim Toxins Incl Trop Dis 2011; 17(2):216-22; http://dx.doi.org/10.1590/S1678-91992011000200013
34. Kazi AM, Shah SA, Jenkins CA, Shepherd BE, Vermund SH. Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan. Int J Infect Dis 2010; 14(Suppl 3):e60-6; PMID:20189863; http://dx.doi.org/10.1016/j. ijid.2009.11.012
35. Reekie JM, Levy MH, Richards AH, Wake CJ, Siddall DA, Beasley HM, Kumar S, Butler TG. Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners - 2004, 2007, 2010. Med J Aust 2014; 200(5):277-80; PMID:24641153; http://dx.doi.org/10.5694/mja13.11062
36. Ramezani A, Amirmoezi R, Volk JE, Aghakhani A, Zarinfar N, McFarland W, Banifazi M, Mostafavi E, Eslamifar A, Sofian M. HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran. AIDS Care 2014; 26(9):1122-6; PMID:24499303; http://dx.doi. org/10.1080/09540121.2014.882485
37. Larney S, Monkley DL, Indig D, Hampton SE. A cross-sectional study of susceptibility to vaccinepreventable diseases among prison entrants in New South Wales. Med J Aust 2013; 198(7):376-9; PMID:23581958; http://dx.doi.org/10.5694/mja12.11110
38. Kolaric B, Stajduhar D, Gajnik D, Rukavina T, Wiessing L. Seroprevalence of blood-borne infections and population sizes estimates in a population of injecting drug users in Croatia. Cent Eur J Public Health 2010; 18(2):104-9; PMID:20939261
39. Allwright S, Bradley F, Long J, Barry J, Thornton L, Parry JV. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ 2000; 321(7253):78-82; PMID:10884256; http://dx.doi. org/10.1136/bmj.321.7253.78
40. Stief AC, Martins RM, Andrade SM, Pompilio MA, Fernandes SM, Murat PG, Mousquer GJ, Teles AS, Camolez GR, Francisco RB, et al. Seroprevalence of hepatitis B virus infection and associated factors among prison inmates in State of Mato Grosso do Sul, Brazil. Rev Soc Bras Med Trop 2010; 43(5): 512-5; PMID:21085860; http://dx.doi.org/10.1590/S0037-86822010000500008
41. Tresó B, Barcsay E, Tarján A, Horváth G, Dencs A, Hettmann A, Csépai MM, Gyori Z, Rusvai E, Takács M. Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary. J Urban Health 2012; 89(1):108-16; PMID:22143408; http://dx.doi.org/10.1007/s11524-011-9626-x
42. Harzke AJ, Goodman KJ, Mullen PD, Baillargeon J. Heterogeneity in hepatitis B virus (HBV) seroprevalence estimates from U.S. adult incarcerated opulations. Ann Epidemiol 2009; 19(9):647-50; PMID:19596205; http://dx.doi.org/10.1016/j.annepidem.2009.04.001
43. Saum C, Surratt H, Inciardi J, Bennett R. Sex in prison: exploring the myths and realities. Prison J 1995; 75(4):413-30; http://dx.doi.org/10.1177/0032855595075004002
44. Hunt DR, Saab S. Viral hepatitis in incarcerated adults: a medical and public health concern. Am J Gastroenterol 2009; 104(4):1024-31; PMID: 19240708; http://dx.doi.org/10.1038/ajg.2008.143
45. Harawa N, Sweat J. Sex and condom use in a large jail unit for men who have sex with men (MSM) and male-to-female transgenders. J Health Care Poor Underserved 2010; 21(3): 1071-87; PMID: 20693745; http://dx.doi.org/10.1353/hpu.0.0349
46. Wolff N, Shi J. Contextualization of physical and sexual assault in male prisons: Incidents and their aftermath. J Correct Heal Care 2009; 15(1):58-82; PMID:19477812; http://dx.doi.org/10.1177/1078345808326622
47. Struckman-Johnson C, Struckman-Johnson D. Sexual coercion reported by women in three midwestern prisons. J Sex Res 2002; 39(3):217-27; PMID:12476269; http://dx.doi.org/10.1080/00224490209552144
48. Schneider K, Richters J, Butler T, Yap L, Richards A, Grant L, Smith AM, Donovan B. Psychological distress and experience of sexual and physical assault among Australian prisoners. Crim Behav Ment Health 2011 Dec; 21(5):333-49; PMID:21671444
49. Hellard ME, Aitken CK, Hocking JS. Tattooing in prisons–not such a pretty picture. Am J Infect Control 2007; 35(7):477-80; PMID:17765561; http://dx.doi.org/10.1016/j.ajic.2006.08.002
50. Hellard ME, Hocking JS, Crofts N. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiol Infect 2004; 132(3):409-15; PMID:15188710; http://dx.doi.org/10.1017/S0950268803001882
51. Vescio MF, Longo B, Babudieri S, Starnini G, Carbonara S, Rezza G, Monarca R. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. J Epidemiol Community Health 2008; 62(4):305-13; PMID:18339822; http://dx.doi.org/10.1136/jech.2006.051599
52. Vong S, Fiore AE, Haight DO, Li J, Borgsmiller N, Kuhnert W, Pinero F, Boaz K, Badsgard T, Mancini C, et al. Vaccination in the county jail as a strategy to reach high risk adults during a community- based hepatitis A outbreak among methamphetamine drug users. Vaccine 2005; 23 (8):1021-8; PMID:15620475; http://dx.doi.org/10.1016/j.vaccine.2004.07.038
53. Zamani S, Farnia M, Torknejad A, Alaei BA, Gholizadeh M, Kasraee F, Ono-Kihara M, Oba K, Kihara M. Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in Iran. J Urban Health 2010; 87(4):603-16; PMID:20390391; http://dx.doi.org/10.1007/s11524-010-9450-8
54. Fox RK, Currie SL, Evans J, Wright TL, Tobler L, Phelps B, Busch MP, Page-Shafer KA. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis United States; 2005 Jul; 41(2):177-86; PMID:15983913; http://dx.doi.org/10.1086/430913
55. Garcia-Guerrero J, Marco A. [Overcrowding in prisons and its impact on health]. Rev Esp Sanid Penit Spain 2012 Feb; 14(3):106-13; PMID:23165634; http://dx.doi.org/10.4321/S1575-06202012000300006
56. Goldenson J, Hennessey M. Correctional health care must be recognized as an integral part of the public health sector. Sex Transm Dis 2009; 36(2 Suppl): S3-4; PMID:19131905; http://dx.doi.org/10.1097/OLQ.0b013e318195ad6c
57. Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS One 2009; 4(11): e7558; PMID:19907649; http://dx.doi.org/10.1371/journal.pone.0007558
58. Farrell M, Marsden J. Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction 2008; 103(2):251-5; PMID:18199304; http://dx.doi.org/10.1111/j.1360-0443.2007.02081.x
59. Bayas JM, Bruguera M, Martin V, Vidal J, Rodes J, Salleras LY. Hepatitis B vaccination in prisons: the Catalonian experience. Vaccine 1993; 11(14):1441-4; PMID:8310764; http://dx.doi.org/10.1016/0264-410X(93)90174-V
60. Catalan-Soares B, Almeida RT, Carneiro-Proietti AB. Prevalence of HIV-1/2, HTLV-I/II, hepatitis B virus (HBV), hepatitis C virus (HCV), Treponema pallidum and Trypanosoma cruzi among prison inmates at. Rev Soc Bras Med Trop 2000; 33(1):27-30; PMID:10881115; http://dx.doi.org/10.1590/S0037-86822000000100004
61. Mamo H. Intestinal parasitic infections among prison inmates and tobacco farm workers in Shewa Robit, north-central Ethiopia. PLoS One 2014; 9(6):e99559; PMID:24926687; http://dx.doi.org/10.1371/journal. pone.0099559
62. World Health Organization. Hepatitis B. Fact Sheet N_ 204, 2014. http://www.who.int/mediacentre/fact sheets/fs204/en/. Accessed January 11, 2015
63. World Hepatitis Alliance. Global Community Hepatitis Policy Report 2014. http://www.worldhepatitisal liance.org/en/civil-society-report-2014.html. Accessed January 11, 2015
64. Dana D, Zary N, Peyman A, Behrooz A. Risk prison and hepatitis B virus infection among inmates with history of drug injection in Isfahan, Iran. Sci World J 2013; 2013: 735761; PMID:23737725; http://dx.doi.org/10.1155/2013/735761
65. Burek V, Horvat J, Butorac K, Mikulić R. Viral hepatitis B, C and HIV infection in Croatian prisons. Epidemiol Infect 2010; 138(11):1610-20; PMID:20202285; http://dx.doi.org/10.1017/S0950268810000476
66. Weild AR, Gill ON, Bennett D, Livingstone SJ, Parry JV, Curran L. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health 2000; 3(2):121-6; PMID:10902255
67. Campollo O, Roman S, Panduro A, Hernandez G, Diaz-Barriga L, Balanzario MC, Cunningham JK. Non-injection drug use and hepatitis C among drug treatment clients in west central Mexico. Drug Alcohol Depend 2012; 123(1–3):269-72; PMID:22138538; http://dx.doi.org/10.1016/j.drugalcdep.2011.11.009
68. Barros LA, Pessoni GC, Teles SA, Souza SM, Matos MA, Martins RM, Del-Rios NH, Matos MA, Carneiro MA. Major article epidemiology of the viral hepatitis B and C in female prisoners of metropolitan regional prison complex in the State of Goiás, Central Brazil. Rev Soc Bras Med Tro 2013; 46:24-9; http://dx.doi.org/10.1590/0037-868216972013
69. Coelho HC, Lourdes MD, Oliveira A, Dinis A, Passos C. Seroprevalence of Hepatitis B virus infection in a brazilian jail. Rev Bras Epidemiol 2009; 12(2):124-31; http://dx.doi.org/10.1590/S1415-790X2009000200003
70. Adjei AA, Armah HB, Gbagbo F, Ampofo WK, Boamah I, Adu-Gyamfi C, Asare I, Hesse IF, Mensah G. Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study. BMC Infect Dis 2008; 8:33; PMID:18328097; http://dx.doi.org/10.1186/1471-2334-8-33
71. Adoga MP, Banwat EB, Forbi JC, Nimzing L, Christopher R, Gyar SD, Agabi YA, Agwale SM. Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria. J Infect Dev Ctries 2008; 3(7):539-47; PMID:19762972
72. Carrieri MP, Rey D, Michel L. Universal hepatitis B virus vaccination in French prisons: breaking down the last barriers. Addiction 2010; 105(7): 1311-2; PMID:20642514; http://dx.doi.org/10.1111/j.1360-0443.2010.02968.x
73. Charuvastra A, Stein J, Schwartzapfel B, Spaulding A, Horowitz E, Macalino G, Rich JD. Hepatitis B vaccination practices in state and federal prisons. Public Health Rep 2001; 116(3):203-9; PMID:12034909; http://dx.doi.org/10.1093/phr/116.3.203
74. Pisu M, Meltzer MI, Lyerla R. Cost-effectiveness of hepatitis B vaccination of prison inmates. Vaccine 2002; 21(3–4):312-21; PMID:12450707; http://dx.doi.org/10.1016/S0264-410X(02)00457-7
75. Dappah E, Howes S, Perkins S. Prevention of communicable disease control in prisons and places of detention. A manual for healthcare workers and other staff. Health Protection Agency and Department of Health 2013. https://www.gov.uk/government/publications/infection-control-in-prisons-and-places-ofdetention. Accessed January 11, 2015
76. Asli AAZ, Moghadami M, Zamiri N, Tolide-ei HR, Heydari ST, Alavian SM, Lankarani KB. Vaccination against hepatitis B among prisoners in Iran: accelerated vs. classic vaccination. Health Policy 2011; 100 (2–3):297-304; PMID:21269722; http://dx.doi.org/10.1016/j.healthpol.2010.12.007
77. Alavian SM. Accelerated vaccination against HBV infection is an important strategy for the control of HBV infection in prisons. Rev Soc Bras Med Trop 2011; 44(5):652-3; PMID:22031090; http://dx.doi. org/10.1590/S0037-86822011000500030
78. World Health Organization. WHO position paper on hepatitis A vaccines – June 2012. Wkly Epidemiol Rec 2012 Jul 13; 87(28/29):261-76; PMID:22905367
79. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 2010 Sep 24;28(41):6653-7; PMID: 20723630; http://dx.doi.org/10.1016/j.vaccine. 2010.08.037
80. Ngui S, Granerod J, Jewes LA, Crowcroft NS, Teo C. Outbreaks of hepatitis A in England and Wales associated with two co-circulating hepatitis A virus strains. J Med Virol 2008; 80(7):1181-8; PMID:18461630; http://dx.doi.org/10.1002/jmv.21207
81. Rapicetta M, Monarca R, Kondili LA, Chionne P, Madonna E, Madeddu G, Soddu A, Candido A, Carbonara S, Mura MS, et al. Hepatitis E virus and hepatitis A virus exposures in an apparently healthy highrisk population in Italy. Infection 2013; 41(1):69-76; PMID:23264095; http://dx.doi.org/10.1007/s15010-012-0385-8
82. Perrett K, Granerod J, Crowcroft N, Carlisle R. Changing epidemiology of hepatitis A: should we be doing more to vaccinate injecting drug users? Commun Dis Public Health 2003; 6(2):97-100; PMID:12889286
83. Franco E, Giambi C, Ialacci R, Coppola RC, Zanetti AR. Risk groups for hepatitis A virus infection. Vaccine 2003; 21(19–20):2224-33; PMID:12744847; http://dx.doi.org/10.1016/S0264-410X(03)00137-3
84. Latimer WW, Moleko A-G, Melnikov A, Mitchell M, Severtson SG, von Thomsen S, Graham C, Alama D, Floyd L. Prevalence and correlates of hepatitis A among adult drug users: the significance of incarceration and race/ethnicity. Vaccine 2007; 25(41):7125-31; PMID:17766016; http://dx.doi.org/10.1016/j.vaccine.2007.07.041
85. Removille N, Origer A, Couffignal S, Vaillant M, Schmit JC, Lair ML. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations. BMC Public Health 2011; 11:351; PMID:21595969; http://dx.doi.org/10.1186/1471-2458-11-351
86. Gondles EF. A call to immunize the correctional population for hepatitis A and B. Am J Med 2005; 118 (Suppl 10A):84S-89S; PMID:16271547; http://dx.doi.org/10.1016/j.amjmed.2005.07.025
87. Weinbaum C, Lyerla R, Margolis HS, Centers for Disease Control and Prevention. Prevention and control of infections with hepatitis viruses in correctional settings. MMWR Recomm Rep 2003; 52(RR-1):1-36; PMID:12562146
88. Coffey E, Young D. Guidance for hepatitis A and B vaccination of drug users in primary care and criteria for audit. Royal College of General Practitioners 2005; p 1-6. http://www.smmgp.org.uk/download/guidance/guidance014.pdf. Accessed January 11, 2015
89. Costumbrado J, Stirland A, Cox G, El-Amin AN, Miranda A, Carter A, Malek M. Implementation of a hepatitis A/B vaccination program using an accelerated schedule among high-risk inmates, Los Angeles County Jail, 2007-2010. Vaccine 2012; 30(48):6878-82; PMID:22989688; http://dx.doi.org/10.1016/j.vaccine.2012.09.006
90. Keystone JS, Hershey JH. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule. Int J Infect Dis 2008;12(1):3-11; PMID:17643334; http://dx.doi.org/10.1016/j.ijid.2007.04.012
91. Jacobs RJ, Rosenthal P, Meyerhoff AS. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates. Vaccine 2004; 22(9–10):1241-8; PMID:15003653; http://dx.doi.org/10.1016/j.vaccine.2003.09.018
92. World Health Organization. Tetanus. Fact Sheets 2012. http://www.wpro.who.int/mediacentre/factsheets/fs_20120307_tetanus/en/. Accessed January 11, 2015
93. World Health Organization. Diphtheria. Immunization, surveillance, assessment and monitoring 2012. http://www.who.int/immunization/monitoring_surveillance/burden/diphtheria/en/. Accessed January 11, 2015
94. World Health Organization. Pertussis. Immunization, Vaccines and Biologicals. http://www.who.int/immu nization/diseases/pertussis/en/. Accessed January 11, 2015
95. Bartlett L, Kanellos-Sutton M, van Wylick R. Immunization rates in a Canadian juvenile corrections facility. J Adolesc Health 2008; 43(6):609-11; PMID:19027650; http://dx.doi.org/10.1016/j.jadohealth.2008.04.008
96. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. second printing.; Atkinson W, Wolfe S, Hamborsky J, eds. 12th ed., Washington DC: Public Health Foundation 2012
97. World Health Organization. Pneumococcal disease. International travel and health 2012. http://www.who.int/ith/diseases/pneumococcal/en/. Accessed January 11, 2015
98. Mehiri-Zghal E, Decousser J-W, Mahjoubi W, Essalah L, El Marzouk N, Ghariani A, Allouch P, Slim- Saidi NL. Molecular epidemiology of a Streptococcus pneumoniae serotype 1 outbreak in a Tunisian jail. Diagn Microbiol Infect Dis 2010; 66(2):225-7; PMID:19800751; http://dx.doi.org/10.1016/j.diagmicrobio.2009.05.008
99. Hoge CW, Reichler MR, Dominguez EA, Bremer JC, Mastro TD, Hendricks KA, Musher DM, Elliott JA, Facklam RR, Breiman RF. An epidemic of Pneumococical disease in an overcrowded, inadequately ventilated jail. N Engl J Med 1994; 331(10):643-8; PMID:8052273; http://dx.doi.org/10.1056/NEJM199409083311004
100. Herbert K, Plugge E, Foster C, Doll H. Prevalence of risk factors for non-communicable diseases in prison populations worldwide: a systematic review. Lancet 2012; 379(9830):1975-82; PMID:22521520; http://dx.doi.org/10.1016/S0140-6736(12)60319-5
101. Bayas J, Vilella A. Vacunas para la población penitenciaria. Rev Española Sanid Penit 2002 [cited 2014 Dec 23]; (4):39-42
102. Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, White CG, Hadler S, Pilishvili T, Centers for Disease Control and Prevention. Use of 13- Valent pneumococcal conjugate vaccine and 23-Valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 2014; 63(37): 822-5; PMID:25233284
103. Centers for Disease Control and Prevention. Use of 13-valent pneumococcal conjugate vaccine and 23- valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 2012; 61(40):816-9; PMID:23051612
104. Public Health England: Health and Justice Team Respiratory Diseases Department, Centre for Disease Surveillance and Control. Guidance on responding to cases or outbreaks of seasonal flu 2014/15 in prisons and other places of detention within the criminal justice system in England. London (UK). Operational guidance 2014. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/371897/Guidanceón_seasonal_flu_2014_to_15_in_prisons.pdf. Accessed December 14, 2015
105. Gómez-Pintado P, Moreno R, Pérez-Valenzuela A, García-Falcés JI, García M, Martínez MA, Acín E, Fernández de la Hoz K. Descripción de los tres primeros brotes de gripe A (H1N1) 2009 notificados en prisiones de España. Rev Esp Sanid Penit 2010; 12 (1):29-36; PMID:23128486
106. Turner KB, Levy MH. Prison outbreak: pandemic (H1N1) 2009 in an Australian prison. Public Health 2010; 124(2):119-21; PMID:20149400; http://dx.doi.org/10.1016/j.puhe.2009.12.005
107. Maruschak LM, Sabol WJ, Potter RH, Reid LC, Cramer EW. Pandemic influenza and jail facilities and populations. Am J Public Health 2009; 99 (SUPPL. 2):S339-44; PMID:19797746; http://dx.doi.org/10.2105/AJPH.2009.175174
108. Health J, Hospital W. Summer outbreak of respiratory disease in an Australian prison due to an influenza A/Fujian/411/2002(H3N2)-like virus. Epidemiol Infect 2005; 133(1):107-12; PMID:15724717; http://dx.doi.org/10.1017/S0950268804003243
109. Stanley L. Influenza at San Quentin Prison, California. Public Health Reports (1896-1970) 1919; 34 (19):996-1008. http://www.jstor.org/stable/4575142. Accessed January 8, 2015; http://dx.doi.org/10.2307/4575142
110. James T, Finnie R, Hall IM, Leach S. Behaviour and control of influenza in institutions and small societies. J R Soc Med 2012; 105(2):66-73; PMID:22357982; http://dx.doi.org/10.1258/jrsm.2012.110249
111. Awofeso N, Fennell M, Waliuzzaman Z, O’Connor C, Pittam D, Boonwaat L, de Kantzow S, Rawlinson WD. Influenza outbreak in a correctional facility. Aust N Z J Public Health 2001; 25(5):443-6; PMID:11688625; http://dx.doi.org/10.1111/j.1467-842X.2001.tb00290.x
112. Public Health England: Health Protection Agency, Prison Infection Prevention Team. Seasonal influenza outbreak at large London prison. Infection Inside 2011; 7(1). http://www.basl.org.uk/uploaded_files/infection%20inside.pdf. Accessed January 5, 2015
113. Centers for Disease Control and Prevention. Receipt of A(H1N1)pdm09 vaccine by prisons and jails - United States, 2009-10 influenza season. MMWR Morb Mortal Wkly Rep 2012; 60(51–52):1737-40; PMID:22217623
114. World Health Organization. Global measles and rubella strategic plan: 2012-2020. Geneva 2012. http://www.who.int/immunization/newsroom/Measles_Rubella_StrategicPlan_2012_2020.pdf?uaD1. Accessed February 10, 2015
115. Gétaz L, Rieder JP, Siegrist CA, Kramer MC, Stoll B, Humair JP, Kossovsky MP, Gaspoz JM, Wolff H. Improvement of measles immunity among migrant populations: lessons learned from a prevalence study in a Swiss prison. Swiss Med Wkly 2011; 141: w13215; PMID:21706449
116. Nowicki D, Gajewska L, Sosada KA. Measles outbreak registered by the District Sanitary-Epidemiological Station in Częstochowa in 2013. Przegl Epidemiol 2014; 68(3):405-9, 517-20
117. Walkty A, Van Caeseele P, Hilderman T, Buchan S, Weiss E, Sloane M, Fatoye B. Mumps in prison: description of an outbreak in Manitoba, Canada. Can J Public Health 2011; 102(5):341-4; PMID:22032098
118. van Boven M, Kretzschmar M, Wallinga J, O’Neill PD, Wichmann O, Hahné S. Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population. J R Soc Interface 2010; 7(52):1537-44; PMID:20392713; http://dx.doi.org/10.1098/rsif.2010.0086
119. Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010; 202(12):1789-99; PMID:21067372; http://dx.doi.org/10.1086/657321
120. Olesen TB, Munk C, Christensen J, Andersen KK, Kjaer SK. Human papillomavirus prevalence among men in sub-Saharan Africa: a systematic review and meta-analysis. Sex Transm Infect 2014; 90(6):455-62; PMID:24812407; http://dx.doi.org/10.1136/sextrans-2013-051456
121. Smith JS, Gilbert PA, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of human papillomavirus infection in males: a global review. J Adolesc Health 2011; 48(6):540-52; PMID:21575812; http://dx.doi.org/10.1016/j.jadohealth.2011.03.010
122. World Health Organization. Human papillomavirus vaccines: WHO position paper. Wkly Epidemiol Rec 2014; 43(89):465-92; PMID:25346960
123. de Aguiar SR, Villanova FE, Martins LC, dos Santos MS, Maciel Jde P, Falcão LF, Fuzii HT, Quaresma JA. Human papillomavirus: prevalence and factors associated in women prisoners population from the Eastern Brazilian Amazon. J Med Virol 2014; 86 (9):1528-33; PMID:24838771; http://dx.doi.org/10.1002/jmv.23972
124. Chu F-Y, Lin Y-S, Cheng S-H. Human papillomavirus infection in human immunodeficiency virus-positive Taiwanese women incarcerated for illicit drug usage. J Microbiol Immunol Infect 2013; 46(4):282-7; PMID:22841621; http://dx.doi.org/10.1016/j.jmii.2012.06.009
125. Canche JR, Canul J, Suárez R, de Anda R, González MR. Infección por el Virus del Papiloma Humano en mujeres recluidas en Centros de Readaptación Social en el sureste de México. Rev Esp Sanid Penit 2011; 13:84-90; PMID:22071487; http://dx.doi.org/10.4321/S1575-06202011000300003
126. de Sanjosé S, Valls I, Paz Cañadas M, Lloveras B, Quintana MJ, Shah KV, Bosch FX. Infección por los virus del papiloma humano y de la inmunodeficiencia humana como factores de riesgo para el cáncer de cuello uterino en mujeres reclusas. Med Clin 2000; 115(3):81-4; PMID:10965480; http://dx.doi.org/10.1016/S0025-7753(00)71472-2
127. González C, Canals J, Ortiz M, Muñoz L, Torres M, García-Saiz A, Del Amo J. Prevalence and determinants of high-risk human papillomavirus (HPV) infection and cervical cytological abnormalities in imprisoned women. Epidemiol Infect 2007; 136:215-21
128. National Health Service England, Public Health England, Health and Justice Team. Public health services for people in prison or other places of detention, including those held in the Children &Young People’s Secure Estate. London (UK) 2013. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/383429/29_public_health_services_for_peo ple_in_prison.pdf. Accessed January 10, 2015
129. Henderson CE, Rich JD, Lally MA. HPV vaccination practices among juvenile justice facilities in the United States. J Adolesc Health 2010; 46(5):495-8; PMID:20413087; http://dx.doi.org/10.1016/j.jadohealth.2009.10.007
130. Binswanger IA, Mueller S, Clark CB, Cropsey KL. Risk factors for cervical cancer in criminal justice settings. J Womens Health (Larchmt) 2011; 20 (12):1839-45; PMID:22004180; http://dx.doi.org/10.1089/jwh.2011.2864
131. Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini JA Jr, Unger ER; Centers for Disease Control and Prevention. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014; 63(RR-05):1-30; PMID:25167164
132. World Health Organization. Meningococcal vaccines: WHO position paper, November 2011. Wkly Epidemiol Rec 2011; 86(47):521-39; PMID:22128384
133. Zhang J, Zhou HJ, Xu L, Hu GC, Zhang XH, Xu SP, Liu ZY, Shao ZJ. Molecular characteristics of Neisseria meningitidis isolated during an outbreak in a jail: association with the spread and distribution of ST- 4821 complex serogroup C clone in China. Biomed Environ Sci 2013; 26(5):331-7; PMID:23611126
134. Tappero JW, Reporter R, Wenger JD, Ward BA, Reeves MW, Missbach TS, Plikaytis BD, Mascola L, Schuchat A. Meningococcal disease in Los Angeles County, California, and among men in the county jails. N Engl J Med 1996; 335:833-40; PMID:8778600; http://dx.doi.org/10.1056/NEJM199609193351201
135. Sathe PV, Mugumdar RD, Mahurkar SD, Sengupta SR. An outbreak of meningococcal meningitis in a prison (epidemiology and control). Indian J Public Health 1971; 15(3):92-6; PMID:5154305
136. World Health Organization, Varicella and Herpes Zoster Vaccination Position Paper – June 2014. http://www.who.int/immunization/position_papers/WHO_pp_varicella_herpes_zoster_june2014_sum mary.pdfAccessed January 8, 2015
137. Leung J, Lopez AS, Tootell E, Baumrind N, Mohle- Boetani J, Leistikow B, Harriman KH, Preas CP, Cosentino G, Bialek SR, et al. Challenges with controlling varicella in prison settings: experience of California, 2010 to 2011. J Correct Health Care 2014; 20 (4):292-301; PMID:25201912; http://dx.doi.org/10.1177/1078345814541535
138. Gétaz L, Siegrist CA, Stoll B, Humair JP, Scherrer Y, Franziskakis C, Sudre P, Gaspoz JM, Wolff H. Chickenpox in a Swiss prison: susceptibility, post-exposure vaccination and control measures. Scand J Infect Dis 2010; 42(11–12):936-40; PMID:20854218; http://dx.doi.org/10.3109/00365548.2010.511259
139. Valdarchi C, Farchi F, Dorrucci M, De Michetti F, Paparella C, Babudieri S, Spano A, Starnini G, Rezza G. Epidemiological investigation of a varicella outbreak in an Italian prison. Scand J Infect Dis 2008; 40 (11–12):943-5; PMID:18720259; http://dx.doi.org/10.1080/00365540802308449
140. Levy MH, Quilty S, Young LC, Hunt W, Matthews R, Robertson PW. Pox in the docks: varicella outbreak in an Australian prison system. Public Health 2003; 117(6):446-51; PMID:14522161; http://dx.doi.org/10.1016/S0033-3506(03)00138-0
141. Haas EJ, Dukhan L, Goldstein L, Lyandres M, Gdalevich M. Use of vaccination in a large outbreak of primary varicella in a detention setting for African immigrants. Int Health 2014; 6(3):203-7; PMID:24682723; http://dx.doi.org/10.1093/inthealth/ihu017
142. World Health Organization. Global Tuberculosis Report, 2014. http://www.who.int/tb/publications/global_report/es/Accessed January 05, 2015
143. World Health Organization. Tuberculosis in prisons Page [Internet]. http://www.who.int/tb/challenges/prisons/en/. Accessed January 10, 2015
144. World Health Organizaction. Literature Review on Tuberculosis in Prisons, 2008. http://www.who.int/tb/challenges/prisons/tb_in_prisons_lit_review_10feb 08.pdf?. Accessed January 12, 2015
145. World Health Organizaction. Implementing the WHO stop TB strategy: A handbook for national tuberculosis control programmes. Geneve 2008. http://whqlibdoc.who.int/publications/2008/9789241546676éng.pdf. Accessed January 12, 2015
146. Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC. Endorsed by the Advisory Council for the Elimination of Tuberculosis, the National Commission on Correctional Health Care, and the American Correctional Association. MMWR Recomm Rep 2006; 55(RR-9):1-44; PMID:16826161
147. Schmitt J, Warner K, Gupta S. The high budgetary cost of incarceration. Washington; DC: Center for Economic and Policy Research; 2010. http://www.cepr.net/documents/publications/incarceration-2010-06.pdf. Accessed April 10, 2015
148. World Health Organization, United Nation Office for Drug and Cirme. Good governance for prison health in the 21st century. Denmark 2013. http://www.euro. who.int/__data/assets/pdf_file/0017/231506/Goodgovernance- for-prison-health-in-the-21st-century.pdf? uaD 1. Accessed January 20, 2015
149. Saiz de la Hoya P. Integración de la Sanidad Penitenciaria. Perspectivas de futuro. Rev Esp Sanid Penit 2012; 2:83-6
150. Departament of Health England. Prison Health Performance and Quality Indicators 2012 [Internet]. https://www.gov.uk/government/publications/prisonhealth- performance-and-quality-indicator-report-andguidance. Accessed January 16, 2015
151. Christensen PBI, Fisker N, Krarup HB, Liebert E, Jaroslavtsev N, Christensen K, Georgsen J. Hepatitis B vaccination in prison with a 3-week schedule is more efficient than the standard 6-month schedule. Vaccine 2004; 22(29–30):3897-901; PMID:15364437; http://dx.doi.org/10.1016/j.vaccine.2004.04.011
152. Freudenberg N. Jails, prisons, and the health of urban populations: a review of the impact of the correctional system on community health. J Urban Health 2001; 78(2):214-35; PMID:11419576; http://dx.doi.org/10.1093/jurban/78.2.214
153. Glaser J, Greifinger R. Correctional health care: a public health opportunity. Ann Intern Med 1993; 1995(5):6-8; PMID:8416310
154. Maher D, Grzemska M, Coninx R, Reyes H. Guidelines for the control of tuberculosis in prisons. WHO/TB/98.250. 1998. http://whqlibdoc.who.int/hq/1998/WHO_TB_98.250.pdf Accesed 8 January, 2015